CL Colgate-palmolive Co
Colgate-Palmolive Co. is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care; and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors. The Pet Nutrition segment offers pet nutrition products for dogs and cats. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Company profile
Ticker
CL
Exchange
CEO
Ian M. Cook / Noel R. Wallace
Employees
Incorporated in
Location
Fiscal year end
Industry (SEC)
SEC CIK
Corporate docs
IRS number
131815595
CL stock data
()
Calendar
26 Jul 19
17 Oct 19
31 Dec 19
News
Company financial data Financial data
| Quarter (USD) | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|
| Revenue | 3.87B | 3.88B | 3.81B | 3.85B | |
| Net income | 586M | 560M | 606M | 523M | |
| Diluted EPS | 0.68 | 0.65 | 0.7 | 0.6 | |
| Net profit margin | 15.16% | 14.42% | 15.90% | 13.60% | |
| Operating income | 888M | 879M | 891M | 874M | |
| Net change in cash | 20M | 117M | -115M | 8M | |
| Cash on hand | 863M | 843M | 726M | 841M | |
| Cost of revenue | 1.56B | 1.6B | 1.56B | 1.58B |
| Annual (USD) | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | 15.54B | 15.45B | 15.2B | 16.03B | |
| Net income | 2.4B | 2.02B | 2.44B | 1.38B | |
| Diluted EPS | 2.75 | 2.28 | 2.72 | 1.52 | |
| Net profit margin | 15.44% | 13.10% | 16.06% | 8.63% | |
| Operating income | 3.69B | 3.71B | 3.96B | 2.79B | |
| Net change in cash | -809M | 220M | 345M | -119M | |
| Cash on hand | 726M | 1.54B | 1.32B | 970M | |
| Cost of revenue | 6.31B | 6.17B | 6.07B | 6.64B |
Financial data from company earnings reports
Financial report summary
?Competition
Church & Dwight • Revlon • Hain Celestial • Prestige Consumer Healthcare • Williamsville Sears Management • Freshpet
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
absence, affirmed, Antimonopoly, Austrian, body, borrowing, Certificate, consummation, duly, Exhibit, Filorga, formatted, Germany, Henning, iii, implicit, iv, Jakobsen, jury, Language, mouthwash, Noel, pay, Philip, proceeding, readily, registered, Russian, thereunto, trial, undersigned, verdict, vi, Wallace, wash, XBRL
Removed:
Australia, India, Kingdom, led, protection, underarm
Financial reports
10-Q
2019 Q2
Quarterly report
26 Jul 19
10-Q
2019 Q1
Quarterly report
26 Apr 19
10-K
2018 FY
Annual report
21 Feb 19
10-Q
2018 Q3
Quarterly report
26 Oct 18
10-Q
2018 Q2
Quarterly report
27 Jul 18
10-Q
2018 Q1
Quarterly report
27 Apr 18
10-K/A
2017 FY
Annual report (amended)
21 Feb 18
10-K
2017 FY
Annual report
15 Feb 18
10-Q
2017 Q3
Quarterly report
27 Oct 17
10-Q
2017 Q2
Quarterly report
21 Jul 17
Current reports
8-K
Other Events
20 Sep 19
8-K
Results of Operations and Financial Condition
26 Jul 19
8-K
Other Events
11 Jul 19
8-K
Departure of Directors or Certain Officers
24 Jun 19
8-K
Departure of Directors or Certain Officers
15 May 19
8-K
Colgate Announces 1st Quarter 2019 Results
26 Apr 19
8-K
Colgate-palmolive Company 2019 Performance Stock Unit Award Agreement
20 Mar 19
8-K
Other Events
26 Feb 19
8-K
Colgate Elects Lisa M. Edwards to Board of Directors
21 Feb 19
8-K
Departure of Directors or Certain Officers
11 Feb 19
Registration and prospectus
25-NSE
Exchange delisting
14 May 19
S-8
Registration of securities for employees
10 May 19
8-A12B
Registration of securities on exchange
6 Mar 19
424B2
Prospectus for primary offering
27 Feb 19
FWP
Free writing prospectus
26 Feb 19
424B2
Prospectus for primary offering
26 Feb 19
424B2
Prospectus for primary offering
31 Oct 17
FWP
Free writing prospectus
31 Oct 17
424B2
Prospectus for primary offering
27 Oct 17
S-3ASR
Automatic shelf registration
27 Oct 17
Proxies
DEFA14A
Additional proxy soliciting materials
18 Apr 19
DEFA14A
Additional proxy soliciting materials
27 Mar 19
DEF 14A
Definitive proxy
27 Mar 19
DEFA14A
Additional proxy soliciting materials
20 Apr 18
DEF 14A
Definitive proxy
28 Mar 18
DEFA14A
Additional proxy soliciting materials
28 Mar 18
DEFA14A
Additional proxy soliciting materials
21 Apr 17
DEF 14A
Definitive proxy
29 Mar 17
DEFA14A
Additional proxy soliciting materials
29 Mar 17
DEFA14A
Additional proxy soliciting materials
19 Apr 16
Other
SD
Conflict minerals disclosure
31 May 19
SD
Conflict minerals disclosure
31 May 18
SD
Conflict minerals disclosure
31 May 17
UPLOAD
Letter from SEC
10 May 17
CORRESP
Correspondence with SEC
27 Apr 17
UPLOAD
Letter from SEC
4 Apr 17
NO ACT
No action letter
1 Feb 17
UPLOAD
Letter from SEC
26 Jul 16
CORRESP
Correspondence with SEC
8 Jul 16
UPLOAD
Letter from SEC
28 Jun 16
Patents
APP
Utility
Oral Care Implement
17 Oct 19
Described herein is an oral care implement comprising a body having a head portion, a gripping portion, and a neck portion located between the head and gripping portions, a plurality of tooth engaging elements extending from the head portion, the body comprising a first component formed of a first hard plastic having a first ductility; and a second component formed of a second hard plastic having a second ductility that is greater than the first ductility.
APP
Utility
Oral Care Implement
17 Oct 19
An oral care implement sanitization system that includes an oral care implement and a case for storing the oral care implement and activating a sanitization or sterilization procedure.
APP
Utility
Oral Treatment Device
17 Oct 19
An oral treatment device that emits light onto surfaces of a user's teeth.
GRANT
Utility
Toothbrush with removable smart device
15 Oct 19
In some embodiments, an oral care system includes a toothbrush and a smart device removably retained in the toothbrush and having a plurality of sensors for sensing conditions of the oral cavity.
GRANT
Utility
Oral care composition
15 Oct 19
Disclosed are oral care compositions, for example dentifrice compositions, comprising an orally acceptable vehicle, metal oxide particles having an average particle size of no greater than a dentin tubule and a polymeric adherent material for adhering the metal oxide particles in the dentin tubule.